IDEAYA Biosciences (FRA:30J) Change In Other Working Capital : €-0.27 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is IDEAYA Biosciences Change In Other Working Capital?

IDEAYA Biosciences's Change In Other Working Capital for the quarter that ended in Mar. 2025 was €0.57 Mil. It means IDEAYA Biosciences's Other Working Capital increased by €0.57 Mil from Dec. 2024 to Mar. 2025 .

IDEAYA Biosciences's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was €-1.31 Mil. It means IDEAYA Biosciences's Other Working Capital declined by €1.31 Mil from Dec. 2023 to Dec. 2024 .

IDEAYA Biosciences Change In Other Working Capital Historical Data

The historical data trend for IDEAYA Biosciences's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEAYA Biosciences Change In Other Working Capital Chart

IDEAYA Biosciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Other Working Capital

Get a 7-Day Free Trial

68.70

-22.20

-45.48

-14.33

-1.31

IDEAYA Biosciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Other Working Capital	Get a 7-Day Free Trial															-0.43	-0.50	-0.25	-0.08	0.57

IDEAYA Biosciences Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.27 Mil.

IDEAYA Biosciences Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of IDEAYA Biosciences's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

IDEAYA Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IDEAYA Biosciences Inc (FRA:30J) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

IDYA:USA

Address

5000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080

Website

https://www.ideayabio.com

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

IDEAYA Biosciences Headlines

No Headlines